Table 4 Baseline characteristics (median (IQR)) of women with decline in eGFR ≥10 ml/min/1.73 m2 at follow-up
From: Short term sequelae of preeclampsia: a single center cohort study
No eGFR decline (n = 170) | eGFR decline (n = 27) | p-value | |
|---|---|---|---|
Age | 33 (28–37) | 31 (27–35) | 0.20 |
Onset (d) | 258 (240–272) | 261 (241–273) | 0.64 |
Early onset | 21.8% (36/165) | 18.5% (5/27) | 0.70 |
Nulliparous | 75.7% (128/169) | 66.7% (18/27) | 0.32 |
Time to f/u (d) | 180 (152–190) | 179 (154–190) | 0.93 |
MD | 15.3% (26/170) | 3.7% (1/27) | 0.10 |
IVF | 7.7% (13/170) | 0% (0/27) | 0.14 |
GD | 8.8% (15/170) | 14.8% (4/27) | 0.33 |
HELLP | 21.2% (36/170) | 18.5% (5/27) | 0.75 |
Severe PE | 70% (119/170) | 48.2% (13/27) | 0.03 |
AKI | 10.1% (17/169) | 0% (0/27) | 0.09 |